No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
SILK Silk Road Medical
- 21.390
- -0.830-3.74%
Close Jun 14 16:00 ET
843.70MMarket Cap-15613P/E (TTM)
22.200High21.080Low540.54KVolume22.000Open22.220Pre Close11.58MTurnover1.40%Turnover RatioLossP/E (Static)39.44MShares33.78052wk High5.73P/B823.89MFloat Cap6.08052wk Low--Dividend TTM38.52MShs Float75.800Historical High--Div YieldTTM5.04%Amplitude6.080Historical Low21.421Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Argus Research Maintains Silk Road Medical(SILK.US) With Buy Rating, Raises Target Price to $32
Argus Research analyst David Toung maintains $Silk Road Medical(SILK.US)$ with a buy rating, and adjusts the target price from $24 to $32.According to TipRanks data, the analyst has a success rate of
Lake Street Maintains Silk Road Medical(SILK.US) With Buy Rating, Maintains Target Price $28
Lake Street analyst Frank Takkinen maintains $Silk Road Medical(SILK.US)$ with a buy rating, and maintains the target price at $28.According to TipRanks data, the analyst has a success rate of 38.5% a
Analysts' Top Healthcare Picks: Silk Road Medical (SILK), Eli Lilly & Co (LLY)
Does Silk Road Medical (NASDAQ:SILK) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved whe
Silk Road Medical | 10-Q: Quarterly report
Silk Road Medical, Inc (NASDAQ:SILK) Q1 2024 Earnings Call Transcript
Comments
Insider's recent share sale at current price is viewed negatively. Absence of insider purchases and history of sales over the past year raises caution for potential investors. Despite insider ownership, alignment with other shareholders is weak.
Rising insider sales at Silk Road Medical and no insider purchases in past year suggest potential dip in stock performance. Also, low insider ownership suggests less motivation for long-term company growth.
This should jump to 9+ no problem
$AMN Healthcare Services(AMN.US$ $CBL International(BANL.US$ $Chanson International(CHSN.US$ $Cryoport(CYRX.US$ $MetLife(MET.US$ $MillerKnoll(MLKN.US$ $Nova Lifestyle(NVFY.US$ $InspireMD(NSPR.US$ $Paramount Global-B(PARA.US$ $Ryder System(R.US$ $Recursion Pharmaceuticals(RXRX.US$ $Silk Road Medical(SILK.US$ $60 Degrees Pharmaceuticals(SXTP.US$ $Uber Technologies(UBER.US$ $Victory Capital(VCTR.US$
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg